Chang David D — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Chang David D is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $289K.
Profile
David D. Chang is an accomplished executive in the biotechnology sector, currently serving as the President and CEO of Allogene Therapeutics, Inc. He has a strong background in the development of innovative therapies and has played a pivotal role in advancing the company's mission to develop allogeneic CAR T cell therapies for cancer treatment. Under his leadership, Allogene has made significant strides in clinical development and has positioned itself as a leader in the field.
Role
President and CEO, Director
Notability
75/100
Board memberships
Allogene Therapeutics, Inc.
Awards & honors
Leadership in developing allogeneic CAR T cell therapies
Advancements in clinical trials for cancer treatment
David D. Chang is an accomplished executive in the biotechnology sector, currently serving as the President and CEO of Allogene Therapeutics, Inc. He has a strong background in the development of innovative therapies and has played a pivotal role in advancing the company's mission to develop allogeneic CAR T cell therapies for cancer treatment. Under his leadership, Allogene ha…
Has Chang David D been buying or selling stock?
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($289K) across all tracked filings.
Where can I see all of Chang David D's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
